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Abstract
Objective: To summarize the available evidence regarding the course of symptoms and prognostic factors in patients with diagnosed carpal tunnel
syndrome (CTS) who are treated conservatively.
Data Sources: Computerized databases, reference checking, and experts in the field were used to identify studies for inclusion in the review.
Study Selection: Multiple reviewers were used to identify studies which included adults (aged 18y) diagnosed with CTS in either a clinical
setting or population setting. The study must have observed the course of CTS over at least a 6-week period in patients receiving no treatment or
usual care that included conservative (nonsurgical) treatments. The design was of a longitudinal cohort study with either prospective or
retrospective data collection. There were no language restrictions, and none of the research identified was only reported in abstract form.
Data Extraction: Methodological bias was assessed using the Quality in Prognosis Studies tool. A high risk of bias (predominantly relating to
study attrition, confounding, and/or statistical analysis and reporting) was judged to be present in 8 studies. Designs showed wide variability with
respect to characteristics of the included population, definition of CTS, assessment of prognostic factors, types of interventions provided, and
types of outcome measures applied. This prevented pooled estimates from being produced.
Data Synthesis: A negative outcome at 3 years’ follow-up of conservatively treated participants ranged from 23% to 89%. Four included
studies observed the rate of surgical intervention after initial conservative management and found this to be 57% to 66%. Evidence regarding
factors predicting the negative outcome of no treatment or conservative treatment was graded, taking into account the number of studies
evaluating the factor, the methodological quality of these studies, and the consistency of the available evidence. There was 100% agreement in
at least 3 cohorts with a medium or high risk of bias that symptom duration, a positive Phalen’s test, and thenar wasting were associated with a
negative outcome of conservative management; however, not all results were statistically significant, and hence the overall judgment remained
inconclusive.
Conclusions: Results of this review should be treated with caution because of the heterogeneity of studies and the risks of bias identified. However,
the course of CTS appears variable, and poor prognosis may be predicted by a longer symptom duration, a positive Phalen’s test, and thenar wasting.
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OpeCarpal tunnel syndrome (CTS) is a chronic focal compressive
neuropathy caused by the entrapment of the median nerve at the
level of the carpal tunnel.1 CTS is the most common of the
entrapment neuropathies, accounting for 90% of presentations,2
and is characterized by numbness, tingling, hand and arm pain,
and muscle dysfunction.3 Between 55% and 65% of CTS cases
present bilaterally,4 and the condition can be associated with hy-
pothyroidism, diabetes, and rheumatoid arthritis, among others.
CTS may present in late pregnancy but is usually transient.n access under CC BY-NC-ND license.
Course and prognosis of carpal tunnel syndrome 837Studies in different countries have reported varying results
with respect to the incidence of CTS.5 A survey of the Ska˚ne
Health Care Register in Sweden by Atroshi et al5 was age adjusted
to the 2000 U.S. standard population to allow comparison with the
results of a U.S.-based survey of the Rochester Epidemiology
Project.6 The estimated incidence of CTS in Sweden was reported
as 324 per 100,000 in women compared with 542 per 100,000 in
the United States, and in men, 166 per 100,000 in Sweden
compared with 303 in the United States.5,6 The explanation for
variation between countries is unknown; however, suggested
possibilities include differences in health careeseeking behavior
and variation in etiologic factors including occupation, diabetes,
and inflammatory joint disease.5
The treatment of CTS is often categorized as either surgical or
conservative (nonsurgical). Surgical treatment is generally rec-
ommended for those with severe CTS (ie, evidence of denervation
of the median nerve), while conservative treatments are recom-
mended for the initial management of those who have intermittent
or mild symptoms or in whom surgery is contraindicated.7 The
U.S. standardized annual incidence of carpal tunnel release sur-
gery per 100,000 persons was 166 in Sweden compared with 171
in the United States and, among men, 58 in Sweden compared
with 96 in the United States.5,6 Examples of conservative treat-
ment include oral steroids, steroid injections, physical therapy,
electrotherapy, night splinting, and workplace alterations.8 In
United Kingdom primary care, steroid injections and night
splinting form the mainstay of conservative treatment options, as
indicated by national care pathways (eg, National Institute for
Health and Care Excellence Clinical Knowledge Summaries).9,10
Guidelines for the management of CTS by the American Asso-
ciation of Orthopaedic Surgeons11 conclude that patients with
more severe and prolonged CTS may not benefit from extended
conservative treatment. However, the authors were unable to
recommend in which patients conservative treatments were un-
likely to be effective.11
Cochrane systematic reviews of conservative treatments for
CTS12 have included the assessment of local corticosteroid in-
jections13 and splinting.7 With respect to splinting, the authors
conclude that there is limited evidence that night splinting is more
effective than no treatment in the short-term. They do, however,
suggest that more research is needed on the long-term effects of
this intervention.7 With regard to steroid injections, it was
concluded that robust evidence demonstrates clinical improvement
up to 1 month compared with placebo, but relief beyond this
period has not yet been shown.13
With ongoing clinical uncertainty regarding the most effective
management strategy for CTS, there is a clear need for a greater
understanding of the likely long-term course of CTS symptoms
(overall prognosis) of the condition and patient factors that may be
associated with outcome (prognostic factors).
Outcomes and predictors of surgical outcome have been well
reported in the literature. However, few studies and no sys-
tematic reviews have been performed to summarize the evidence
for prognosis and prognostic factors in conservatively managed
diseasedthat is, that which can be delivered in a primary care
environment. An estimate of average prognosis is required by
public health policymakers in order for the population burden ofList of abbreviations:
CTS carpal tunnel syndrome
QUIPS Quality in Prognosis Studies
www.archives-pmr.orga condition to be assessed. Understanding the future outcomes
of patients with a particular condition in relation to current
practice and even in the absence of clinical care (the natural
history) is crucial because it allows the potential impact of in-
terventions to be more fully assessed.14 Such information is not
only important when considering the potential benefits of in-
terventions, but also in order to inform patients, clinicians, and
policymakers of the potential harms, variations (such as
underuse, overuse, misuse), and potential impact on health care
efficiencies.14
This systematic review and narrative synthesis initially focuses
on summarizing the prognosis research regarding the general
course of CTS. The “start point” of this review will be the point of
diagnosis of CTS that is being treated conservatively or with no
clinical treatment. The “endpoint” will vary depending on the
primary study. This synthesis therefore seeks to describe the
course of CTS being managed either with no intervention or with
conservative approaches.
The second part of this systematic review aims to identify
predictors of long-term outcome (prognostic factors) in CTS. A
prognostic factor is “any measure that, among people with a given
health condition (start point), is associated with a subsequent
clinical outcome (endpoint).”15(p1) Prognostic factor research thus
seeks to identify the predictive value of such factors.
Research of prognostic factors aims to identify features that
could potentially contribute to the development of prognostic
models or represent predictors of differential treatment response,
which may further contribute to a stratified care approach to a
condition. Prognostic factors may also represent modifiable targets
for interventions and could hence lead to the development of new
management strategies through an improved understanding of
disease mechanisms.15Methods
Identification and selection of literature
Details of the protocol for this systematic review were regis-
tered on PROSPERO (CRD42013006608) and can be accessed
at http://www.crd.york.ac.uk/PROSPERO/display_record.asp?
IDZCRD42013006608#.VYk_RflVhBc. Eligible publications
had to report the course of CTS symptoms (persistence/
recovery or severity of pain or other symptoms) and/or the
association between a potential prognostic factor and outcome,
as well as meeting the following eligibility criteria: (1) The
study included adults (aged 18y) diagnosed with CTS in
either a clinical setting or population setting. Studies in preg-
nant women and in populations such as specific occupational
groups were excluded. (2) The study observed the course of
CTS over at least a 6-week period in patients receiving no
treatment or usual care that included conservative (nonsurgical)
treatments. Studies reporting risk factors for onset of CTS as
opposed to predictors of outcome were excluded, as were
studies investigating predictors of the effectiveness of a specific
treatment (which would ideally require a review of randomized
controlled trials and is planned for the future). (3) The design
was of a longitudinal cohort study with either prospective or
retrospective data collection. (4) There were no language re-
strictions, and none of the research identified was only reported
in abstract form.
Table 1 Levels of evidence for prognostic factors17,18
Level of Evidence Definition
Strong Consistent findings (75%) in at least 2
cohorts with a low risk of bias
Moderate Consistent findings (75%) in 1 cohort with
a low risk of bias and at least 1 cohort with
a moderate/high risk of bias
Weak Findings of 1 cohort with a low risk of bias or
consistent findings (75%) in at least 3
cohorts with a moderate/high risk of bias
Inconclusive Inconsistent findings irrespective of study
quality, or less than 3 cohorts with a
moderate/high risk of bias
No evidence No data presented
838 C.L. Burton et alA systematic computerized search of the literature was con-
ducted in MEDLINE, Embase, AMED, HMIC, PsycINFO,
CINAHL, Cochrane, SCI-EXPANDED, and CPCI-S from their
inception until December 2013. The MEDLINE search strategy
can be found in supplemental appendix S1 (available online only
at http://www.archives-pmr.org/). References of all included full-
text articles were hand-searched, and the first 15 pages of Goo-
gle Scholar results for “carpal tunnel syndrome” and “prognosis”
were screened as a further check for relevant hits. Experts were
contacted to identify any further studies or publications in the gray
literature that had not been identified in the search. The titles were
screened by 1 reviewer (C.B.) and abstracts were screened by 2
reviewers (C.B., L.C.), and full articles of potentially eligible
studies were retrieved. Such articles were screened by the 2 re-
viewers independently for eligibility and included in the review if
they met the prespecified criteria.Quality assessment
All selected studies were assessed independently for quality by 2
reviewers (C.B. and L.C.) using the Quality in Prognosis Studies
(QUIPS) tool.16 The QUIPS tool assesses bias in the following 6
domains: (1) study participation; (2) study attrition; (3) prognostic
factor measurement; (4) outcome measurement; (5) study con-
founding; and (6) statistical analysis and reporting. Judgments of
low, moderate, or high risk of bias were made for each applicable
domain using descriptors recommended by Hayden et al.16 Sum-
mated scores for overall study quality are not generally recom-
mended; however, assessment of the overall risk of bias is
suggested to be useful when synthesizing existing evidence.16
With the use of suggestions from Hayden,16 studies were judged
to be of low overall risk of bias if all or most of the domains were
judged as low risk, and studies in which all or most of the domains
were judged as high risk were considered to be of high overall risk
of bias. Studies with a moderate risk of bias were those with all or
most of the domains being judged as moderate risk. Differences
between reviewers were discussed, and a decision was made by
agreement. Agreement between reviewers (C.B., L.C.) regarding
the judgment of overall risk of bias was presented as a percentage
of agreement.Data extraction
Data were extracted by 1 reviewer (C.B.) and checked by another
reviewer (L.C.). Data extraction included details of the study
setting, population demographics, diagnostic criteria of CTS
used, management approaches used, prognostic factors (type of
factors and how measured), outcome measures (definition and
instrument used), sample size, rate of attrition, and length of
follow-up. With regard to clinical course, the percentage of
patients with a negative outcome after conservative treatment or
no treatment was recorded. All reported prognostic factors were
listed and measures of association with their significance
levels recorded.Analysis
Results regarding the course of symptoms in patients with un-
treated and conservatively treated CTS were summarized narra-
tively. Pooling of results was not possible because of
heterogeneity with regard to study setting, case definition, follow-up periods, and measures of outcome. We summarized findings
for the reported prognostic factors by taking into account the
number of studies evaluating the factor, the risk of bias of these
studies, and the consistency of the available evidence (as defined
as significant association with the same direction). A level of
evidence was defined for each factor, based on Sackett17 and
Ariens18 and colleagues, and adapted for use with the QUIPS
tool (table 1).Results
Selection of studies
Figure 1 presents a flow chart of study selection. A total of 15,572
citations were identified (6987 MEDLINE, 6445 Embase, 197
AMED, 19 HMIC, 92 PsycINFO, 707 CINAHL, 755 Cochrane,
370 SCI-EXPANDED and CPCI-S). After the removal of dupli-
cates and a screen of the titles, 146 abstracts were screened and 42
full-text publications retrieved for further eligibility screening.
Twenty-six articles were excluded for the following reasons: 1
foreign language duplicate was found; 3 studies reported condi-
tions not specific to CTS (ie, wrist pain or unspecified entrapment
neuropathies); 6 studies reported outcomes in a specific popula-
tion; 4 studies reported the etiology of CTS only; 6 studies re-
ported on outcomes of specific treatments; and 6 studies used a
design other than that described in the selection criteria. Sixteen
articles (reporting on 16 cohorts) met all eligibility criteria and
were included in the review.
Study characteristics
Table 2 summarizes the characteristics of the studies including
the QUIPS score, study design and setting, study population, in-
terventions used in the study, the primary outcome measure
including the definition of a negative outcome, and the duration of
follow-up. The table also presents the percentage of the cohort
experiencing a negative outcome (eg, surgery) of conservative or
no management.
One study19 was a retrospective follow-up study of cases
identified in the Marshfield Epidemiologic Study Area, a
population-based cohort. All other studies were based in sec-
ondary or tertiary care, of which 6 were in surgical clinics and 8
in electromyography laboratories. No studies were based inwww.archives-pmr.org
Fig 1 Study selection.
Course and prognosis of carpal tunnel syndrome 839primary care. The case definitions used to identify CTS differed: 6
studies used clinical features only, while the remaining 10 studies
required accompanying electrophysiological abnormalities. The
combination of clinical characteristics used and the electrophys-
iological criteria also varied between studies. The interventions
used in the studies included wrist splinting (7 studies), nonste-
roidal anti-inflammatory drugs (3 studies), other analgesia (2
studies), oral steroids (3 studies), local steroid injections (6
studies), and paraffin treatment (1 study). Three studies provided
conservative management without specifying which mode exactly.
In 4 studies,20-23 the course of (clinically) untreated CTS was
observed. In some studies, parts of the cohort were treated sur-
gically. Their specific outcomes were not included in this review.
A range of outcome measures were used: 3 studies used a surgical
episode as a proxy for a negative outcome; 1 study used the
shortened version of the Disabilities of the Arm, Shoulder and
Hand questionnaire (QuickDASH) score; 5 used measures of
global improvement; 2 used a change in symptom and function
severity scores; 1 used the Historic and Objective Scale24; 1 used
work absence; 2 observed electrophysiological changes; and 1www.archives-pmr.orgused absence of clinical contact as an indicator of recovery. The
follow-up periods ranged from 12 weeks to 10 years.
Methodological quality
The results of the quality assessment are presented in table 3. In 4
studies that investigated the course of CTS symptoms only, the
prognostic factor domain was not assessed. The percentage
agreement between the authors (C.B., L.C.) with regard to judg-
ment of the overall risk of bias was 75%, and 100% after dis-
cussion. Further adjudication was therefore not required.
Eight studies were judged to have a moderate risk of bias and 8
to have a high risk of bias. The domains that carried a particularly
high risk of bias across all studies were study attrition (12 studies),
study confounding (10 studies), and statistical analysis and
reporting (9 studies). Study attrition tended to be at high risk of
bias because the response rates in several studies were low (see
table 3), attempts to collect information on participants who
dropped out were often lacking, reasons for loss to follow-up were
rarely provided, and differences between those lost to follow-up
Table 2 Summary of study characteristics and results regarding the course of symptoms of prognostic cohort studies in CTS
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Measure of Negative
Outcome of Conservative
Management
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Treated Populations: Prospective Cohort Studies
Boyd et al,33
2005,
Canada
High Setting: tertiary hand and
upper limb center
CTS diagnosis: clinical findings
and electrophysiological
abnormality
68% female
Mean age: 49.3y
NZ25 patients (47 wrists)
Dropout: 17%
Splint: all wrists
Surgery: 27 (57%) wrists
No surgery vs surgery by
6mo
12wk, with an option to
continue follow-up >6mo
Progression to surgery 57% of wrists
Duckworth
et al,34
2013,
Scotland
Moderate Setting: hand clinic
CTS diagnosis: clinical findings
and electrophysiological
abnormality
67% female
Mean age  SD: males 5714y;
females 5414y
NZ275 patients
Dropout: 28%
Splint: all patients
Injection: 150 (55%)
(of whom 38 had
surgery)
Surgery: 122 (44%)
patients
No further treatment: 3
(1%) patients
QuickDASH score
1y
Progression to surgery 58% of patients
Goodwill,31
1965,
England
High Setting: electromyography
laboratory
CTS diagnosis: paresthesia and
pain with
electrophysiological
abnormality
93% female
Age bands:
30e39y: nZ7 patients
40e49y: nZ19
50e59y: nZ39
60e69y: nZ18
70y: nZ13
NZ96 patients (155 wrists)
Dropout: 0%
Splint: 98 (63%) wrists
Injection: 58 (37%)
wrists
Surgery: 55 (35%) wrists
Judgment made at follow-
up: cured, temporary
relief, or no relief
1e3y (average 14mo)
Evidence of symptoms After steroid injection: 88%
of patients
After splinting: 89% of
patients
After surgery: 5% of
patients
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Table 2 (continued )
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Measure of Negative
Outcome of Conservative
Management
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Kaplan et al,27
1990,
United
States
High Setting: hand clinic
CTS diagnosis: presence of pain
or paresthesia and clinical
findings (thenar atrophy,
altered sensation, or Phalen’s
sign) 75% female
Mean age: 55y
NZ229 patients (331 wrists)
Dropout: 12%
Splint: “most patients”
Nonsteroidal anti-
inflammatory drugs:
149 (65.2%) patients
Oral steroid: 61 (26.8%)
patients
Steroid injection: 38
(16.4%) patients
Success of therapy as
defined by absence of
symptoms for >6mo
Minimum of 6mo or until
had surgical release
(average 15.4mo)
Evidence of symptoms after
6mo
Progression to surgery
82% of wrists
66% of wrists
Katz et al,30
1998,
United
States
Moderate Setting: surgical clinics
CTS diagnosis: paresthesia
involving at least 2 digits
(thumb or index, middle or
ring fingers) and symptom
duration of at least 1mo
74% female
Surgical cohort: >55y mean
age  SD, 68.09.1y; <55y
compensation nonrecipient
mean age  SD 42.07.3y;
compensation recipient
mean age  SD, 39.08.1y.
Nonsurgical cohort >55y mean
age  SD, 64.07.0y;
compensation nonrecipient
mean age  SD, 41.08.9y;
compensation recipient
mean age  SD, 37.08.8y
NZ297 patients
Dropout: 31%
Nonsurgical cohort: 34
patients received
surgery at <3mo and
were not included in
analyses.
By 30mo:
Splint: 76 (94%)
patients
Injection: 36 (44%)
patients
Physical or occupational
therapy: all
Change in status in
symptom severity,
functional limitations,
and health status were
recorded over time.
Associations were
measured for patients
crossing between
nonsurgical and surgical
cohorts after >3mo.
Follow-up took place at 6,
18, and 30mo
Would not be happy to live
the rest of their lives
with symptoms
60% of patients
(continued on next page)
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Table 2 (continued )
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Measure of Negative
Outcome of Conservative
Management
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Kiylioglu
et al,26
2009,
Turkey
Moderate Setting: electromyography
laboratory
CTS diagnosis: clinical findings,
supported by
electrophysiological
abnormality
90% female
Diabetic rehabilitation group
mean age  SD, 59.37.4y;
diabetic untreated group
mean age  SD,
54.611.1y; idiopathic
rehabilitation group mean
age  SD, 47.89.9y;
idiopathic surgery group
mean age  SD, 49.29.8y
NZ42 patients (80 wrists)
Dropout: 0 (assumed)
Treatment methods not
controlled or
standardized
“Rehabilitation”:
patients treated with
splints, paraffin
treatments, and/or
oral nonsteroidal
anti-inflammatories
Symptom severity score and
functional status (Boston
questionnaire translated
into Turkish)
Patients were followed up
in the early follow-up
period (3e5mo) and late
follow-up period
(6e12mo).
Percentage improvement in
symptom severity scale
Percentage improvement
in function severity scale
Rehabilitation 82%
Surgery 77%
Untreated 25%
Rehabilitation 73%
Surgery 85%
Untreated 17%
Treated Populations: Retrospective Cohort Studies
Kouyoumdjian
et al,32
2003,
Brazil
High Setting: electromyography
laboratory
CTS diagnosis: symptoms
including hand paresthesia,
numbness, and pain mainly
at night.
95.8% female
Surgical cure group mean age
46y (range, 24e70);
unchanged/worse group 44y
(range, 39e58y);
nonsurgical cure group mean
age 61y (range, 48e79y);
worse group mean age 50y
(range, 30e83y)
NZ165 patients (222 wrists)
Dropout: 69%
Surgery: 147 (66%)
wrists
Nonsurgical (splint,
local injection,
medication, and
others): 75 (34%)
wrists
General patient
satisfaction: complete
relief; improved “much
better”; improved
“little”; unchanged;
worsened
Poorly recorded. Between 5
and 10y (mean, 5.9y after
surgery)
Symptoms unchanged or
worse
23.7% of wrists
(continued on next page)
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Table 2 (continued )
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Measure of Negative
Outcome of Conservative
Management
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Lian et al,25
2006,
Singapore
High Setting: electromyography
laboratory
CTS diagnosis: clinical history
and examination, confirmed
using American Association
of Electrodiagnostic
Medicine criteria and
additional testing if this was
normal
81.3% female
Mean age: 53.6y
NZ115
Dropout: 14%
Conservative
management: 88
(77%) patients
Surgery: 27 (23%)
patients
Clinician review of medical
records and decision
made as to category:
resolved; improved;
same; worse
Follow-up took place at 3
and 6mo (limited data
available)
Symptoms unchanged or
worse
68.5% of patients
Miranda
et al,35
2013,
United
Kingdom
High Setting: plastic surgery clinic
CTS diagnosis: based on clinical
symptoms
Sex not reported
Mean age  SD: 563y
NZ134
Dropout 10%
Injection: 66 (49%)
patients
Surgery: 68 (51%)
patients
Symptom relief and/or
surgery
22.50.5mo
Progression to surgery 62% of patients
Muhlau et al,28
1984,
Germany
Moderate Setting: electromyography
laboratory
CTS diagnosis: distal motor
latency was >4.7ms
Sex and age not reported
NZ157 (214 wrists)
Dropout: 38%
Conservative
management: 72
(48%) wrists
Surgery: 112 (52%)
wrists
An overall categorization
was made at follow-up:
cured; clear
improvement; slight
improvement; unchanged
findings; further
deterioration. These were
then dichotomized so
that groups 1 and 2 Z
cured, and 3, 4, and 5 Z
not cured.
Follow-up was at least 2y
and defined as when the
patient had reached a
“steady state.”
No evidence of cure 68% of patients
(continued on next page)
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Table 2 (continued )
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Measure of Negative
Outcome of Conservative
Management
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Treated Populations: Retrospective Follow-Up Study of a Population-Based Case Series
DeStefano
et al,19
1997,
United
States
Moderate Setting: patients identified
from the Marshfield
Epidemiologic Study Area
CTS diagnosis: ICD-9-CM code
354.0 and evidence of a
clinical and/or
electrophysiological
abnormality in the records.
62% female
Mean age: 62y
NZ425
Dropout: 0%
Analgesia: 143 (34%)
patients
Nonsteroidal anti-
inflammatories: 132
(31%) patients
Injection: 6 (1%)
patients
Splint: 295 (69%)
patients
Surgery: 198 (47%)
patients
No surgery vs surgery and
resolution of symptoms
Median follow- up
1979e1983: 12.0y (5th
and 95th percentiles:
10.0 and 14.8y,
respectively).
1984e1988: 7.3y
(5.0e9.8y)
Evidence of symptoms 1mo: 75% of patients
2y: 40%
8y: 22%
Treated Populations: Secondary Analysis of Katz et al,30 1998
Katz et al,29
1998,
United
States
Moderate Setting: surgical clinics
CTS diagnosis: paresthesia
involving at least 2 digits
(thumb or index, middle or
ring fingers) and symptom
duration of at least 1mo
72% female
Mean age  SD: 4311y
NZ253 patients
Dropout: 20%
Surgery: 179 (71%)
patients
Out of work at 18mo
Questionnaires were
completed at 6, 18, and
30mo.
Work absence at 18mo due
to CTS
23% of patients
Untreated Populations: Prospective Cohort Studies
Ortiz-Corredor
et al,22
2008,
Columbia
High Setting: electromyography
laboratory
CTS diagnosis: as per Rempel
et al,36 1998
81.1% female
Mean age  SD: 48.810.2y
NZ132 patients
Not possible to determine
dropout
The course of untreated
CTS was observed.
The Historic and Objective
Scale was used as the
clinical classification.
The electrophysiological
classification was
according to Padua et
al,37 1997 (mild;
moderate A; moderate B;
severe; extreme)
24.24.2mo
Deterioration in the
Historic and Objective
Scale
23.4% of patients
(continued on next page)
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Table 2 (continued )
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Measure of Negative
Outcome of Conservative
Management
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Padua et al,20
1998,
Italy
Moderate Setting: electromyography
laboratory
CTS diagnosis: based on
neurophysiological
evaluation graded: negative,
minimal, mild, moderate,
severe, and extreme (Padua
et al20)
78.8% female
Mean age  SD: 48.810.2y
NZ80
Dropout: 84%
The course of untreated
CTS was observed.
Patient-reported global
improvement scale:
stable, worse, improved
Neurophysiological
classification: negative,
minimal, mild, moderate,
severe, extreme
11.6mo (range, 5e23)
Clinical outcome:
unchanged
Clinical outcome: worse
Neurophysiological
classification
Negative 50%
Minimal 38%
Mild 15%
Moderate 27.5%
Severe 0%
Extreme 50%
Negative 50%
Minimal 31%
Mild 58%
Moderate 45%
Severe 20%
Extreme 0%
Padua et al,21
2001,
Italy
Moderate Setting: electromyography
laboratory
CTS diagnosis: based on clinical
diagnostic criteria proposed
by the American Academy of
Neurology and the American
Association of
Electrodiagnostic Medicine
82% female
Mean age  SD: 52.013.4y
NZ202 (267 wrists) with a
further 62 (87 wrists)
reevaluated by telephone
Dropout: 34%
The course of untreated
CTS was observed.
Electrophysiological
changes, patient-
reported changes, and
clinical changes were
used to describe if
patients had improved,
remained stationary, or
worsened.
10e15mo
Neurophysiologic class
Symptoms
Function
Historic and Objective Scale
Pain
Stationary 57%
Worsening 16%
Stationary 45%
Worsening 21%
Stationary 61%
Worsening 16%
Stationary 46%
Worsening 32%
Stationary 62%
Worsening 12%
(continued on next page)
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Table 2 (continued )
Author,
Year,
Location
Risk of
Bias
(QUIPS
Score) Study Population
Interventions Provided
to Entire Cohort
Primary Outcome Measure/
Duration of Follow-Up
Meas of Negative
Outc of Conservative
Mana ent
Proportion of Patients
Treated Conservatively
Experiencing Negative
Outcome
Untreated Populations: Retrospective Cohort Studies
Resende
et al,23
2003,
Brazil
High Setting: electromyography
laboratory
CTS diagnosis: clinical findings,
supported by
electrophysiological
abnormality
NZ12
Dropout not possible to
determine
The course of untreated
CTS was observed.
Clinical and
electrophysiological
changes were observed.
4e9y
Cond ion studies Marked improvement 25%
(of which 100% had
improvement in
symptoms)
Slight improvement 15%
(of which 33% had
worsening of clinical
symptoms)
No significant change 50%
(of which 50% had
worsening of clinical
symptoms)
Worsening 10% (of which
50% had worsening of
clinical symptoms)
NOTE. Compensation recipient and nonrecipient indicates that the patient received compensation or did not receive compensation, respectively, owing litigation proceedings.
Abbreviations: ICD-9-CM, International Classification of Diseasese9th RevisioneClinical Modifications; QuickDASH, shortened version of the Disabil of the Arm, Shoulder and Hand questionnaire.
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Table 3 Results of methodological assessment of prognostic cohort studies on CTS
Author, Year
Study
Participation
Study
Attrition
Prognostic
Factor
Measurement
Outcome
Measurement
Study
Confounding
Statistical
Analysis and
Reporting
Overall Risk
of Bias
Studies Including an Analysis of Prognostic Factors
Boyd et al,33
2005
High High Moderate Moderate Moderate High High
DeStefano
et al,19
1997
Low Moderate Moderate Moderate Moderate Moderate Moderate
Duckworth
et al,34
2013
Moderate High Moderate Moderate High Low Moderate
Goodwill,31
1965
High High High High High High High
Kaplan et al,27
1990
High High High High High High High
Katz et al,30
1998
Low Moderate Moderate Moderate Low High Moderate
Katz et al,29
1998
Low High Moderate Low High Low Moderate
Kiylioglu
et al,26
2009
Moderate High Moderate Moderate Moderate High Moderate
Kouyoumdjian
et al,32
2003
Moderate High Moderate Moderate High High High
Muhlau
et al,28
1984
Moderate High Low Moderate Moderate Low Moderate
Padua et al,21
2001
Low Moderate Low Moderate Moderate Moderate Moderate
Studies Observing the Course of CTS Only (With No Analysis of Prognostic Factors)
Lian et al,25
2006
High High NA High High High High
Miranda
et al,35
2013
High High NA High High High High
Ortiz-Corredor
et al,22
2008
Moderate Moderate NA Low High High High
Padua et al,20
1998
High High NA Low High Low Moderate
Resende
et al,23
2003
High High NA High High Moderate High
Abbreviation: NA, not applicable.
Course and prognosis of carpal tunnel syndrome 847and those actively followed up were not frequently compared.
Study confounding was also a frequent finding largely because
not all potential confounders were appropriately accounted for,
and hence the observed associations of the potential prognostic
factors with outcome were likely to be at least partly explained
by other (unmeasured) factors. This was particularly true in
studies using retrospectively collected data. Statistical analysis
and reporting was commonly identified as being of high risk of
bias because presentation of the data was frequently insuffi-
cient, and in some studies selective reporting of results
was evident.www.archives-pmr.orgCourse of CTS
For each included study, table 2 describes results regarding the
course of CTS in conservatively treated or untreated patients by
describing the proportion of patients who experience a negative
outcome, the definition of which varied between studies (ie,
persisting or worsening symptoms, progression to surgery, or
work absence because of CTS). Table 4 further summarizes re-
sults regarding the course of CTS in terms of the percentage of
patients reporting a negative outcome for different follow-up
time points.
Table 4 Course of CTS in conservatively treated or untreated patients
No. of Studies Sample Size Range
% of Cases Reporting Deterioration Within:
3mo 6mo 12mo 3y 15y
Untreated cases
420-23 12e344 NA NA 32e58 23.4 50
Studies observing cases receiving surgery as a consequence of conservative management failure (% of patients receiving surgery NOT outcome
of surgery)
427,33-35 47e331 NA 57 58 62e66 NA
Studies of conservatively managed patients reporting other definitions of negative outcome
919,25-32 80e425 68.5e75 82 % improvement of up to 82%* 23e89 22e23.7
NOTE. The percentages shown are not cumulative, since it cannot be assumsed that patients reporting a change in symptoms at 6 months would not
have reported something different at an earlier or later date if the study had provided them with such opportunity.
Abbreviation: NA, not applicable.
* Percent change provided in positive direction.26
848 C.L. Burton et alFour studies examined the course of untreated CTS.20-23 Ortiz-
Corredor et al22 observed that of 132 patients with untreated CTS
over a 2-year period, 23.5% showed a deterioration in the Historic
and Objective Scale score, but most cases did not show an elec-
trophysiological deterioration (89 remained the same, 33 recov-
ered, and 10 deteriorated). Only 1 patient had both an
electrophysiological and clinical deterioration. Padua et al20 re-
ported whether the clinical outcome was unchanged or worse in
groups of patients with different electrophysiological classifica-
tions. They found the clinical outcome was worse in 50% of pa-
tients with negative electrophysiology, 27.5% with moderate
studies, and 50% with extreme studies. Padua et al21 further
observed the electrophysiological, symptomatic, functional, His-
toric and Objective Scale, and pain changes in patients with CTS.
They reported that 16%, 21%, 16%, 32%, and 12% of patients in
each of these outcome areas worsened, while 27%, 34%, 23%,
23%, and 26% of patients improved. Resende et al23 presented the
change in electrophysiological measures and accompanying
change in symptoms over a 4- to 9-year period and found that 25%
of patients had a marked improvement in electrophysiological
outcome (100% of whom had improvement in terms of symp-
toms); 15% showed slight improvement (of whom 33% had
worsening of symptoms); 50% showed no significant change (of
whom 50% had worsening in terms of symptoms); and 10% had a
worsening of electrophysiological measurements (of whom 50%
had a worsening of clinical symptoms).
In summary, 32% to 58% of participants receiving no treat-
ment were reported to have a negative outcome at 12 months’
follow-up in 2 studies,20,21 both of which were of moderate risk of
bias. The 2 further studies reporting at 3 and 10 years were at high
risk of bias and reported a negative outcome in 23.4%22 and
50%23 of participants.
In the 9 cohorts receiving conservative treatment, 68.5% to 75%
of patients were reported to have a negative outcome within 3
months’ follow-up25,26; 82%within 6months27; 23% to 89%within
3 years19,28-31; and 22% to 24% within 10 years.28,32 A wide vari-
ation in findingswas noted according to risk of bias, with studies of a
moderate risk of bias appearing to show lower percentages of
patients with a negative outcome (eg, 23%e68% at 3y19,28-30),
comparedwith studies of high risk of bias (82% at 6mo27 and 89%at
3y31). Four studies27,33-35 used a surgical episode as a marker of
negative outcome of conservative management. A range of 57% to
66% of patients were observed to receive surgery after conservative
management over a period of 1 to 3 years.27,33-35In summary, the reported course of conservatively managed
CTS is highly variable, but symptoms do improve over time.
Prognostic factors predicting negative outcome
of CTS
Eleven of the studies presented data on the association between
potential prognostic factors and a negative outcome of conserva-
tively managed CTS. Table 5 presents potential prognostic factors
observed in the studies and reported associations. Not all studies
presented estimates of associations with confidence intervals.
Some presented P values only; some simply reported a finding as
nonsignificant. Therefore, the number of studies investigating each
association, the number of studies of moderate or high risk of bias
(none were of low risk), and the number showing an association
(direction and significance) are summarized.
In total, 39 potential prognostic factors were identified from
the studies. All of these were found to have inconclusive levels of
evidence of an association with a negative outcome. This was due
to inconsistencies in study findings, nonsignificant results, low
numbers of studies investigating each factor, and the moderate to
high risk of bias of the studies included.Discussion
This study is the first systematic review of the prognosis of
conservatively managed CTS. A substantial amount of heteroge-
neity exists in terms of study setting, case definition, follow-up
periods, and measures of outcome between the included studies,
which prevented a meta-analysis from being conducted. A best-
evidence synthesis was therefore presented.
Course of CTS
Four studies20-23 observed the course of untreated CTS, which is
helpful when considering the need for or impact of treatment.
These studies suggest that a proportion (28%e62%)20-23 of pa-
tients will recover or not deteriorate further in the absence of
treatment, and hence a certain period of “watchful waiting” (not
clearly defined by the available evidence) may be considered
clinically when discussing treatment options with patients. When
considering potential mechanisms for recovery (not including
mechanisms of treatment) Padua20 suggests that certain undefinedwww.archives-pmr.org
Table 5 Prognostic factors and strength of association for an unfavorable outcome of CTS in patients who are conservatively treated or
untreated
Prognostic Factor
Direction of
Association and
Significance
Risk of Bias
(No. of
Studies)
No. and % of Studies
Demonstrating Predictive
Association With a Negative
Outcome (Statistically
Significant) Level of Evidence
Demographic characteristics
Female sex þ*,34
þ19
028-30
027
Moderate (5)
High (1)
2/6: 33%
(1/6: 17%)
Inconclusive
Increasing age (group not
otherwise specified or >50y)
þ*,21,29 Moderate (7) 3/10: 30%
(3/10: 30%)
Inconclusive
028,30
*,19,26,34
þ*,27
*,33
32
High (3)
Obesity þ19
*,26
Moderate (2) 1/2: 50%
(0/2: 0%)
Inconclusive
Litigation þ*,29 Moderate (3) 1/3: 33%
(1/3: 33%)
Inconclusive
028,30
Deprivation quintile 34 Moderate (1) 0/1: 0% Inconclusive
Vibration tool use 34 Moderate (1) 0/1: 0% Inconclusive
Occupation status þ*,29 Moderate (1) (1/1: 100%) Inconclusive
Smoking þ34 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
Comorbidity
Diabetes þ*,26 Moderate (1) (1/1: 100%) Inconclusive
Diabetes or hypothyroid þ19 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
Pregnancy or injury-associated CTS 19 Moderate (1) 0/1: 0% Inconclusive
Arthritis þ19 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
Previous fracture or sprain 027 High (1) 0/1: 0% Inconclusive
Stenosing flexor tenosynovitis þ*,27 High (1) (1/1: 100%) Inconclusive
Mental health status þ*,29 Moderate (1) (1/1: 100%) Inconclusive
Disease characteristics
Tinel’s sign positive þ34 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
Phalen’s sign positive þ*,21 Moderate (2)
High (1)
3/3: 100%
(2/3: 67%)
Inconclusive
þ34
þ*,27
Thenar wasting þ*,28 Moderate (2)
High (1)
3/3: 100%
(2/3: 67%)
Inconclusive
þ34
þ*,27
Paresthesia þ*,27 High (1) (1/1: 100%) Inconclusive
Abnormal 2-point discrimination 030
þ*,27
Moderate (1)
High (1)
1/2: 50%
(1/2: 50%)
Inconclusive
Semmes-Weinstein monofilament
testing
030 Moderate 0/1: 0% Inconclusive
Electrophysiological severity þ34
026
*,21
Moderate (3)
High (2)
2/5: 40%
(0/5: 0%)
Inconclusive
þ31
32
Symptom severity *,26 Moderate (2)
High (1)
1/3: 33%
(1/3: 33%)
Inconclusive
*,21
þ*,33
(continued on next page)
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Table 5 (continued )
Prognostic Factor
Direction of
Association and
Significance
Risk of Bias
(No. of
Studies)
No. and % of Studies
Demonstrating Predictive
Association With a Negative
Outcome (Statistically
Significant) Level of Evidence
Functional severity þ*,29
*,21,26
033
Moderate (3)
High (1)
1/4: 25%
(1/4: 25%)
Inconclusive
CTS category of severity19 þ*,19 Moderate (1) (1/1: 100%) Inconclusive
Sensory SF-MPQ þ34 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
Affective SF-MPQ þ34 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
SF-36 033 High (1) 0/1: 0% Inconclusive
DASH 033 High (1) 0/1: 0% Inconclusive
Hi-Ob *,21 Moderate (1) 0/1: 0% Inconclusive
Visual analog scale þ34 Moderate (1) 1/1: 100%
(0/1: 0%)
Inconclusive
Laterality: left only 19 Moderate (1) 0/1: 0% Inconclusive
Laterality: right only *,19 Moderate (1) 0/1: 0% Inconclusive
Laterality: left > right 19 Moderate (1) 0/1: 0% Inconclusive
Laterality: right > left 19 Moderate (1) 0/1: 0% Inconclusive
Bilateral þ*,21 Moderate (2)
High (1)
2/3: 67%
(1/3: 33%)
Inconclusive
þ34
027
Grip strength 030
34
Moderate (2) 0/2: 0% Inconclusive
Hand stress *,21 Moderate (1) 0/1: 0% Inconclusive
Increasing symptom duration þ*,28,21 Moderate (3)
High (2)
5/5: 100%
(3/5: 60%)
Inconclusive
þ26
þ*,27
þ32
NOTE. 0, not significant and direction not provided; þ, predictive of a negative outcome; , not predictive of a negative outcome.
Abbreviations: DASH, Disabilities of the Arm, Shoulder and Hand questionnaire; Hi-Ob, Historical and Objective Scale; SF-36, Medical Outcomes Study
36-Item Short-Form Health Survey; SF-MPQ, Short-Form McGill Pain Questionnaire.
* Statistically significant.
850 C.L. Burton et alCTS cases are self-limiting because of a process of neural adap-
tion, whereby the functional relationship between the nerve and
the carpal tunnel adapts over time.
Because of outcomes being measured at discrete time points by
each study, it was not possible to provide a cumulative percentage
of patients recovering in each period and thus provide clearer
information about what is happening to patients with CTS over
time. Table 4 does, however, show that a proportion of patients can
be observed to have deteriorated from baseline at any point be-
tween 3 months and 10 years, suggesting that the course of CTS is
likely to be highly variable. It is possible that the studies with
longer follow-up periods are representative of patients who
improve and relapse over time, but since none of the studies were
designed to observe the longitudinal course of CTS (ie, at a week-
to-week or month-to-month level), such a symptom course could
not be illustrated by this review.
With regard to symptom relapse, only 1 study31 specifically
addressed this issue. Goodwill31 reported that 85% of patients
initially responding to conservative treatment approaches relapsed
within 1 to 4 years. The possibility of future relapse therefore puts
into question the observations of all studies conducted over a
shorter time frame. A further consideration is that a recurrence ofsymptoms after a conservative treatment that then responds to a
further episode of conservative management (if deemed clinically
appropriate) may not necessarily represent treatment failure.
However, longitudinal data that may describe this phenomenon
were not available, again emphasizing the importance of long-
term studies with repeated assessment of symptoms in patients
with CTS.
The observed between-study variability may be partially
explained by substantial differences in study setting, study design,
case definitions, interventions (the effectiveness of which cannot
be compared between studies), and outcomes used, but possibly
also by differences in patient or disease factors (potential prog-
nostic factors) between studies.
Prognostic factors predicting negative outcome of
conservatively managed CTS
Because of inconsistencies between study findings and the lack of
studies with a low risk of bias, it was not possible to identify
conclusive evidence for any of the factors reported by individual
studies to predict a negative outcome of conservative manage-
ment. There was, however, 100% agreement in at least 3 or morewww.archives-pmr.org
Course and prognosis of carpal tunnel syndrome 851cohorts with a medium or high risk of bias that symptom duration,
a positive Phalen’s test, and thenar wasting were associated with a
negative outcome of conservative management. However, not all
results were statistically significant, and hence the overall judg-
ment remained inconclusive.
Because of a lack of robustness in design and conduct of most
of the included studies, the overall body of evidence identified was
felt to be of moderate and high risk of bias. This limited whether
the synthesized evidence could be considered as conclusive, and
as such, evidence regarding the prognosis of untreated and
conservatively treated CTS remains weak. To improve future
research, key recommendations would include identifying patients
with CTS at baseline using a robust case definition of the condi-
tion. Patients should be followed up for a prolonged period (>3y),
preferably at a number of time points using a clinically mean-
ingful, valid, and reliable outcome measure. This would allow a
longitudinal picture of CTS to be mapped. Attempts could be
made to reduce attrition or better describe the risk of attrition bias
by collecting information from nonresponders and to provide a
description and reason for any loss to follow-up. Ideally, all po-
tential prognostic factors should be included and measured at
baseline using valid and reliable measures.16
To capture the start point of the condition and its earliest
management, it would be beneficial to set such a study in primary
care, where it is likely most patients present initially with their
symptoms and commence treatment.
Study limitations
We searched electronic databases considered to be important and
relevant to the topic. Titles were screened by 1 person because of the
significant number; therefore human error may have led to some
titles being missed. Studies not included in databases and not
identified through reference checking, Google Scholar, and expert
advice may have been overlooked, such as unpublished cohort
studies. Because the review did not find strong evidence for any of
the prognostic factors, it is unlikely that further unpublished mate-
rial would have strongly influenced our conclusions. The review
focused on studies observing the course of symptoms in patients
being treated conservatively for CTS but excluded cohorts being
allocated specific treatments. Predictors of differential treatment
response (moderators) are best identified by randomized trials, and
therefore a further systematic review of these studies is planned.
Results of studies presenting only descriptive results and P
values were included in the review without any risk estimates. All
evidence found could therefore be included, but there is a possi-
bility that the lack of statistical significance was due to small
sample sizes and hence represent a lack of evidence for some of
the prognostic factors rather than a genuine absence of associa-
tion. Future prognosis research in the area of CTS should therefore
ensure that estimates of associations with outcome are adequately
reported and that the study population is of adequate sample size
to investigate the hypothesized associations with outcome.
The unit of analysis differed between studies; that is, some
analyzed outcomes at the patient level (not necessarily taking into
account the laterality of the condition), while others analyzed
outcomes at the wrist level (ie, patients with bilateral symptoms
may be included as 2 cases, not taking dependence of outcomes
within individuals into account). Issues relating to the statistical
analysis of bilateral CTS have been discussed at length for clinical
trials by Page et al.38 A unit-of-analysis error, which may give rise
to overly narrow confidence intervals and small P values, maywww.archives-pmr.orgoccur when data are analyzed on the basis of the number of wrists
without adjustment for nonindependence.38 Such an error may
also occur in prognosis research, including the reviewed studies,
and be a further source of bias. Future prognostic studies should,
where possible, take into consideration this risk of bias in their
design and analysis plan.
Implications for clinical practice
Patients presenting with CTS can be informed of the possibility
of recovery with no treatment or conservative treatment (ie, that
they will not require surgery); however, factors that help to
predict their likelihood of falling into this group have not been
robustly determined. Increasing symptom duration, a positive
Phalen’s test, and thenar atrophy are likely to be prognostic
factors of poor outcome of conservatively managed CTS but
need confirmation in further well-designed prognostic studies.
The review did not identify electrophysiological severity as a
significant predictor of a negative outcome of conservative
management. This may have implications for services that ration
surgery to patients with more severe results and suggests that
other factors should be taken into consideration alongside lab-
oratory investigations.Conclusions
In this review, we found useful descriptions of both the course of
untreated CTS and that of conservatively managed CTS. Although
none of the studies were of low risk of bias, studies of moderate
and high risk of bias showed a widely ranging course of symp-
toms, with 23% to 89% of participants reporting a negative
outcome at 3 years’ follow-up. We found no consistent evidence to
support factors that predict future outcome and that help to explain
the wide variability in the course of symptoms.
There is likely to be an optimum time by which conservative
management should be deemed to have failed and surgical
intervention considered in order to prevent long-term harm,
although this point has not been clearly determined, nor is it
clearly possible to predict which patients may be included in
this group.Keywords
Carpal tunnel syndrome; Disease management; Prognosis;
Rehabilitation
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Supplemental Appendix S1 Medline Search
Strategy
1. median neuropathy/ or exp carpal tunnel syndrome/
2. “carpal tunnel syndrome”.mp. [mpZtitle, abstract, original
title, name of substance word, subject heading word, keyword
heading word, protocol supplementary concept, rare disease
supplementary concept, unique identifier]
3. Nerve Compression Syndromes/
4. entrapment neuropath*.ti,ab.
5. exp Median Nerve/
6. nerve entrapment*.ti,ab.
7. Hand/ and Pain/
8. Pain/ and Wrist/
9. (carpal$ adj3 tunnel$).mp.
10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9
11. exp Prognosis/
12. exp Disease Progression/
13. prognos*.mp.
14. predict*.mp.
15. factor*.mp.
16. risk*.mp.
17. model*.mp.
18. evolution.mp.
19. history.mp.
20. indicator*.mp.
21. course.mp.
22. rule*.mp.
23. transition*.mp.
24. determinant*.mp.
25. pattern*.mp.
26. subgroup*.mp.
27. sub-group*.mp.
28. screen*.mp.
29. long-term.mp.
30. progress*.mp.
31. modif*.mp.
32. mediat*.mp.
33. or/11-32
34. exp Epidemiologic Studies/
35. cohort*.mp.
36. follow-up.mp.
37. follow-up.mp.
38. (“case control” or “case controlled”).mp.
39. retrospective*.mp.
40. prospective*.mp.
41. ((patient* or medical) adj3 (record* or review* or
histor*)).mp.
42. longitudinal*.mp.
43. inception.mp.
44. observation*.mp.
45. time series.mp.
46. outcome*.mp.
47. or/34-46
48. 33 and 47
49. 10 and 48
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